Evidence for single-limb exercises on exercise capacity, quality of life, and dyspnea in patients with chronic obstructive pulmonary disease or chronic heart failure. 
Introduction
Exercise intolerance with increased dyspnea and leg fatigue are key disabling factors in chronic obstructive pulmonary disease (COPD). 1 Increased dyspnea during physical activity is also associated with a lower quality of life (QoL). 2 Another common disease with similar symptoms is chronic heart failure (CHF). Patients with CHF primarily suffer from a circulatory limitation, while patients with COPD are mostly ventilatory limited. [2] [3] [4] However, coexisting COPD and CHF is common as approximately 20-30% of patients with COPD have CHF. 5 The reduced exercise capacity in patients with COPD as well as those with CHF can to some extent be explained by muscle atrophy and weakness, which are determinants seen in both disorders. 6 In these patients, exercise intolerance has a great impact on QoL. 7 Exercise training was found to be effective in both patients with COPD and patients with CHF, and is thus recommended to be included in the treatment according to treatment guidelines. 2, 8, 9 Training intensity is an important determinant of the physiological response to exercise training, and there is moderate scientific evidence that indicates that training at a higher exercise intensity produces greater physiological benefits compared to lower intensity exercises in patients with COPD. 10 The primary methods of exercise training within pulmonary rehabilitation have traditionally been different types of exercises incorporating a large amount of muscle mass, such as walking and cycling exercise regimens. However, the chronic airflow limitation in patients with COPD leads to dynamic hyperinflation and increased dyspnea during these whole body/large muscle mass exercises. This causes many patients with COPD to stop exercising before their cardiovascular system or skeletal muscles are maximally stressed.
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In turn, the result is that many patients with COPD are restricted to low-intensity exercises 12 and thereby obtain less physiological effects compared to if a 4 higher intensity was reached. 10 Training using a reduced muscle mass is a way of dealing with this issue. This was found to give a higher metabolic rate in the exercising muscle due to less stress placed on the respiratory system compared to whole body exercises. 13 A reduced ventilatory demand during exercise might allow for a higher amount of maximal work and more intense exercise training, leading to greater training effects compared to traditional bilateral exercises.
11,13
Studies have demonstrated a higher amount of maximal work (per unit of muscle mass) using a reduced simultaneous muscle mass by the use of single limb exercises (SLE) (i.e. training using one leg/arm at a time) in patients with COPD. The results were explained by decreased stress on the respiratory system as ventilation is reduced in comparison to whole body exercises. 3, 13 Similar to patients with COPD, patients with CHF have demonstrated positive effects of SLE. 14 The positive effects of SLE in patients with CHF have been explained by a maintained peripheral blood flow and muscle perfusion compared to exercise involving a major muscle mass. 15 If the stress on the respiratory and circulatory systems could decrease by the use of SLE regimes, the local work load in the peripheral muscles during training would increase which may lead to better muscle specific training responses compared to training regimes incorporating a larger amount of muscle mass. 13, 14 There is an increasing demand in healthcare that the interventions applied should be supported by scientific evidence. 16 Although SLE regimes have been used as exercise training in both patients with COPD and patients with CHF, the evidence to support the use of these interventions has not been evaluated systematically, and thus remains unclear.
The result of this systematic review will determine the current evidence for SLE regimes and present implications for practice and future research.
Purpose
To determine the evidence for SLE regimes, we systematically reviewed randomized controlled trials that assessed the efficacy of these interventions, compared to any comparator, on any relevant outcome measurement for exercise capacity, QoL and dyspnea in patients with COPD or CHF.
Methods

Protocol and registration
On March 1, 2011 searches were performed in the Database of Abstract of Reviews of Effects and the Cochrane Database of Systematic Reviews to check whether there were already existing or ongoing reviews. A review protocol was created in accordance with the Centre for 
Eligibility criteria
Participants
Studies were included if they were studies of adult participants with a clinical diagnosis of stable COPD according to GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria 2 or studies of participants with CHF according to NYHA (New York Heart Association).
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Studies that included a mixed population where COPD and/or CHF were not the primary diagnosis (at least 90% of study population within inclusion criteria) were excluded.
Interventions
Studies examining SLE, supervised or unsupervised in both in-and out-patient populations were included. SLE was defined as any exercise intervention using one arm or one leg at a time (50% or more of the training had to consist of SLE). Studies not fulfilling these criteria were excluded.
Comparators
Studies comparing the SLE regimes with any intervention, no intervention or placebo interventions were included. No exclusions were made with regard to comparator used.
Outcome measures
Pre-decided outcomes were used in this systematic review. A ranking of the importance of these outcomes has been constructed in collaboration with experts in COPD and CHF rehabilitation. The ranking is based on the importance for patients in accordance with Studies with outcome measurements not relevant for exercise capacity and/or QoL were excluded. Dyspnea was, despite importance, defined as a secondary outcome because of the likely lack of reporting in studies.
Studies
Only peer reviewed English language randomized controlled trials (RCTs) have been included in this systematic review. Unpublished studies, ongoing studies, studies with only abstract available, or studies with no statistical comparison between groups were excluded.
No restrictions regarding publication date were imposed.
Information sources
Electronic searches
The Development, conduction and documentation of search and search strategy were performed by one of the review authors with the assistance of the search coordinators of the Cochrane Airways and Heart groups.
Searching other resources
The related articles function in PubMed was used on included studies from the electronic searches. Reference lists of these included studies and other potentially relevant primary studies, as well as review articles, were searched for further RCTs. In addition, authors of included studies from all searches were contacted about their related studies or knowledge of additional studies.
Data collection and analysis
Selection of studies
Inclusion and exclusion of studies were carried out in three steps using a standardized sheet based on eligibility criteria. These steps were: 1) all titles were read and examined by one author and irrelevant studies were excluded; 2) the abstracts were independently read and examined by two reviewers and irrelevant studies were excluded; 3) entire articles were independently read and studies not meeting inclusion criteria were excluded. Data extraction was performed individually. If unsure, or if only one of the reviewers had approved the study, a decision was reached through discussion between the reviewers. If agreement could not be reached, a third independent reviewer was involved and a majority decision was taken.
Agreement between review authors on study inclusion was measured using Kappa statistics.
Data extraction
Data extraction was individually performed by two review authors with a standardized and pilot tested (on two potentially relevant randomly selected studies during preliminary searches) data extraction form as recommended.
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All authors of included studies were contacted to obtain sufficient data for analysis of evidence grade, including test of heterogeneity, according to GRADE (Grading of Recommendations Assessment, Development and Evaluation).
22-26
Data items
Pre-specified information regarding PICOS (Participants, Intervention, Comparator(s), Outcome(s), and Study) was extracted -further specifications are presented in Table 1 . In addition, recommended items to identify possible duplicate publications to minimize risk for biased results were extracted, if available.
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Assessment of risk of bias in individual studies
The methodological study quality of included RCTs was then measured by the PEDro scale 27 and the Cochrane risk of bias tool 21 in an unblinded manner at both study and outcome level.
Both scales were used to give a broader judgment of study quality. We graded the risk of bias in each domain as low (-), high (+) or unclear (?). On the PEDro scale, the 10 internal validity items were rated '1/0 (Yes/ No)' giving a sum score of 0-10. First the articles were rated independently and consensus was reached after discussion.
Quality of evidence
The results of included RCTs were then compiled and evidence graded by two review authors using the GRADE-system.
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Evidence based on RCTs starts as high, although the evidence may be decreased for one or more of the following reasons: study limitations, inconsistency of results, indirectness of evidence, or imprecision or reporting bias.
22,24
The Domains of GRADE were rated NA, 0, ?, -1 or -2; a further description is found in Appendix 3. Metaanalyses were not performed because heterogeneous interventions and outcome measurements were used. Results are presented for COPD and CHF separately. The primary outcome measures were difference in effect on pre-specified exercise capacity outcomes and disease specific QoL questionnaires. Assessments of heterogeneity were performed in accordance to GRADE guidelines, if sufficient information was available. No additional analyses were performed.
Results
The high-sensitivity search strategy used in this review resulted in a total of 5257 potentially relevant studies. Nine articles met inclusion criteria.
14, [28] [29] [30] [31] [32] [33] [34] [35] However, of these nine studies, . In these instances, according to PICOS characteristics, the study with the largest amount of information was included and any additional outcomes data reported in the other studies were incorporated into the review. There were a total of six unique studies that met all eligibility criteria, and were thus included in this systematic review. A flowchart of the search strategies used is presented in Figure 2 . The agreement between review authors on study inclusion was κ =0.94.
Figure 2 about here
Description of studies
Characteristics of the included studies are described below and presented separately in Table   1 . The reasons for exclusion of trials are presented in Appendix 4.
Included studies
Methods/study: The six included studies were all English language RCT publications.
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Two studies involved patients with COPD 33, 34 , and four studies involved patients with CHF.
29-32
Participants: The included studies consisted of 130 adult participants, 41 (15 male) patients with COPD 33, 34 and 89 (63 male) patients with CHF.
In the COPD trials, disease severity was at least moderate (stage II) COPD (GOLD criteria) 2 , and in the CHF trials, disease severity was between stage I-III (NYHA criteria). were used in CHF studies. The frequency was three times a week for 7-8 weeks in COPD trials 33, 34 , and three times a week for 8-12 weeks in CHF trials .
Percentage of peak heart rate 34 and percentage of peak power 33 were used to determine the intensity in the COPD trials.
Percentage of peak workload [30] [31] [32] and perceived exertion (according to Borg RPE scale , CHF SingLimbSW/E (20-60 min) and OneLegKneeExt (39-45 min).
30,31
Comparator: The COPD SLE regime was compared to two-legged cycling.
33,34
The CHF SLE regimes were compared to no intervention 29, 31 , two legged knee-extensor training on a modified cycle ergometer
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, and two-legged cycle ergometer training.
30,32
Outcomes: All pre-decided outcomes ( Figure 1 ) except local muscle endurance and sub maximal minute V E were incorporated in at least one trial. The primary outcome exercise capacity was evaluated in all six trials [29] [30] [31] [32] [33] [34] and QoL was evaluated in three CHF trials.
29-31
The secondary outcome, dyspnea, was evaluated in one COPD study.
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All outcome assessments were evaluated pre-and directly post-intervention with no additional follow-up.
Excluded studies
The majority of studies were excluded during the screening of titles. The major reasons for exclusion during screening of abstracts and full-text studies were that the studies did not fulfill the intervention inclusion criteria (n=30) or that they were not RCTs (n=14). An overview of judgments is provided in Figure 3 , and a detailed description is given in Appendix 5.
Figure 3 about here
Syntheses of results
Due to heterogeneous interventions and outcome measures used in the six included studies in this systematic review a narrative description of results was selected. The absolute difference between groups is presented in the text to aid in determining the relevance of the magnitude of effect. Quality assessment, summary of findings and evidence grade for each outcome based on GRADE are presented in Table 2 .
Exercise capacity
One-legged cycling (OneLegCycl)
Maximal exercise capacity during an incremental cycle ergometer test was measured in both COPD trials. A lower score on SIP indicates higher QoL.
Dyspnea
No significant difference was found on dyspnea when comparing one-legged to two-legged cycling.
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Risk of bias across studies
No test of the risk of bias across studies was performed due to lack of sufficient information.
All authors were contacted, but only one 32 provided sufficient information. All outcomes in the CHF trials were measured in one study only, making heterogeneity analyses not applicable. No additional analyses were performed. 
Discussion
The aim of the systematic review was to determine the current evidence for SLE regimes in patients with COPD and in patients with CHF. Six unique RCTs were identified, and the current strength of the overall evidence ranges from low to very low, to support the use of SLE regimes compared to non-SLE regimes or control groups receiving no intervention. The low methodological quality of included studies is the major reason for the current evidence for SLE regimes in patients with COPD or CHF.
In patients with COPD, low to very low quality scientific evidence supports the use of OneLegCycl compared to two-legged cycling regarding exercise capacity outcome measures and low quality scientific evidence indicates no difference on dyspnea. These results are applicable in patients with COPD (> stage II), training in hospital settings. QoL was not reported in any COPD study.
In patients with CHF, low quality scientific evidence indicates improved muscle strength using SingLimbSW combined with two-legged cycling compared to using two-legged cycling alone. SingLimbSE improved exercise capacity compared to a control receiving no intervention. Furthermore low quality scientific evidence also indicates that OneLegKneeExt is more effective than both two-legged cycle ergometer training and control groups on a majority of exercise capacity outcomes. However, two-legged knee extensor training is more effective for improving meters walked and some portions of QoL. SingLimbSE and
OneLegKneeExt are significantly better for improving QoL compared to control groups, but no significant differences were found compared to two-legged cycle ergometer training.
These results are applicable in patients with CHF (stage I -III). Dyspnea was not reported in any CHF trial.
As stated in GRADE Dyspnea was only evaluated in one COPD study and no differences between groups were found.
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None of the included CHF trials [29] [30] [31] [32] reported any outcome measure for dyspnea.
Quality of studies
The major limitations of the included studies are the low methodological quality (average 
Methodological considerations
This review was constructed in accordance with PRISMA guidelines.
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The strength of this review is the high-sensitivity search strategy used to minimize the risk of missing potentially relevant studies and the randomized designs of included studies. However, the decision to only include RCTs in combination with the limitation to only include English language publications may have resulted in potentially relevant studies being omitted. The lack of homogeneity in the included studies on SLE strategies and outcome measures used prevented the pooling of data and the execution of meta-analyses.
Conclusions Implications for practice
Incorporating SLE regimes in rehabilitation programs for patients with COPD and patients with CHF might be of benefit. The findings of this systematic review indicate that SLE regimes have positive effects on exercise capacity in patients with COPD and on exercise capacity and QoL in patients with CHF. The positive effects of SLE regimes in both conditions were seen on exercise capacity outcomes considered important or critical for decision making. The evidence at this time is presented in Table 3 . However, the strength of these conclusions is considered low to very low in accordance with GRADE, and further research is very likely to have an important impact in our confidence in the estimate of effect.
Nevertheless a low GRADE rating [22] [23] [24] [25] [26] may be sufficient for implementing an exercise regimen in clinical settings if other demands are met.
16 Table 3 about here
Implications for future research
There is a lack of well described high-quality studies especially comparing the effects of one SLE regime over another for both patients with COPD and patients with CHF. To increase the quality of RCTs the CONSORT guidelines 
Funding
The study was funded with grant support from The Swedish Research Council and the Medical Faculty Umeå University. The funders had no role in review design, conduction, data collection and analysis, decision to publish, preparation or reporting of the systematic review.
Disclosure statement
No conflict of interest exists
28.
Gordon A, Tyni-Lenne R, Persson H, Kaijser L, Hultman E, Sylven C. Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure. Clin Cardiol. 1996;19(7):568-574. *29. Tyni-Lenne R, Dencker K, Gordon A, Jansson E, Sylven C. Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure. Eur J Heart Fail. 2001;3(1):47-52. *30. Tyni-Lenne R, Gordon A, Jensen-Urstad M, Dencker K, Jansson E, Sylven C.
Aerobic training involving a minor muscle mass shows greater efficiency than training involving a major muscle mass in chronic heart failure patients. J Card Fail. 1999;5(4):300-307. *31. Tyni-Lenne R, Gordon A, Sylven C. Improved quality of life in chronic heart failure patients following local endurance training with leg muscles. Step 1
Step 2 Abbreviations: Amb; Ambulation (SIP subscale), CHF; Chronic heart failure, Em; Emotional (LiHfe subscale), COPD; Chronic obstructive pulmonary disease, G; group, GOLD; Global initiative for chronic obstructive lung diseases, HM; Health Management (SIP subscale), LiHfe; Minnesota living with heart failure questionnaire, NS; Non significant, NYHA; New York heart association, PEDro; Physiotherapy evidence database, Phy Dim; Physical Dimension (SIP subscale), Phys; Physical (LiHfe subscale), Psy Dim; Psychosocial Dimension (SIP subscale), RM; Repetitions maximum, S; significant, SI; Social Interaction (SIP subscale), SIP; Sickness Impact profil, S&R; Sleep and rest (SIP subscale), SOC; Sense of coherence scale V E; Minute ventilation, VO 2 Incomplete outcome data, unclear judgment of risk of bias in combination with low Pedro score, one study only, few events and sparse data 9 Unclear judgment of risk of bias in combination with low Pedro score, one study only, few events and sparse data. 10 No blinding of participants and personnel, incomplete outcome data, selective outcomes reported, one study only, few events and sparse data 
Step3
